YU2394A - Lizin so 6-hloro-5-fluoro-3-(-2-tenoil)-2-oksindol-1-karboksamida - Google Patents

Lizin so 6-hloro-5-fluoro-3-(-2-tenoil)-2-oksindol-1-karboksamida

Info

Publication number
YU2394A
YU2394A YU2394A YU2394A YU2394A YU 2394 A YU2394 A YU 2394A YU 2394 A YU2394 A YU 2394A YU 2394 A YU2394 A YU 2394A YU 2394 A YU2394 A YU 2394A
Authority
YU
Yugoslavia
Prior art keywords
fluoro
chloro
tenoil
lizine
oxindol
Prior art date
Application number
YU2394A
Other languages
English (en)
Other versions
YU48719B (sh
Inventor
K. Cooper
T. Crawford
B. Littman
C. Pazoles
S. Ruggeri
K. Wilner
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/007,217 external-priority patent/US5298522A/en
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of YU2394A publication Critical patent/YU2394A/sh
Publication of YU48719B publication Critical patent/YU48719B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

Pronalazak se odnosi na novu lizin so 6-hloro-5-fluoro-3-(2-tenoil)-2-oksindol-l-karbok-samida i farmaceutsku smešu koja obuhvata lizin so 6-hloro-5-fluoro-3-(2-tenoil)-2-oksindol-l-karboksamida i farmaceutski prihvatljivu podlogu.
YU2394A 1993-01-22 1994-01-21 Lizin so 6-hloro-5-fluoro-3-(2-tenoil)-2-oksindol-1-karboksamida YU48719B (sh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/007,217 US5298522A (en) 1993-01-22 1993-01-22 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio
US13827793A 1993-10-18 1993-10-18

Publications (2)

Publication Number Publication Date
YU2394A true YU2394A (sh) 1996-10-18
YU48719B YU48719B (sh) 1999-07-28

Family

ID=26676677

Family Applications (1)

Application Number Title Priority Date Filing Date
YU2394A YU48719B (sh) 1993-01-22 1994-01-21 Lizin so 6-hloro-5-fluoro-3-(2-tenoil)-2-oksindol-1-karboksamida

Country Status (27)

Country Link
EP (1) EP0680321B1 (sh)
JP (1) JP2711939B2 (sh)
CN (1) CN1116822A (sh)
AP (1) AP468A (sh)
AT (1) ATE171373T1 (sh)
AU (1) AU671533B2 (sh)
BG (1) BG61966B1 (sh)
BR (1) BR9405661A (sh)
CA (1) CA2153050C (sh)
CZ (1) CZ182895A3 (sh)
DE (1) DE69413518T2 (sh)
DK (1) DK0680321T3 (sh)
DZ (1) DZ1748A1 (sh)
ES (1) ES2122236T3 (sh)
FI (1) FI940309A (sh)
HU (1) HUT69687A (sh)
IL (1) IL108326A0 (sh)
LV (1) LV10920B (sh)
MA (1) MA23095A1 (sh)
NO (1) NO952904L (sh)
NZ (1) NZ261449A (sh)
OA (1) OA10173A (sh)
PL (1) PL309957A1 (sh)
SK (1) SK91395A3 (sh)
UY (1) UY23723A1 (sh)
WO (1) WO1994016694A1 (sh)
YU (1) YU48719B (sh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997022605A1 (en) * 1995-12-19 1997-06-26 Pfizer Inc. Stable, long acting salts of indole derivatives for the treatment of joint diseases
EP0826685A1 (en) * 1996-08-21 1998-03-04 Pfizer Inc. Stable, long acting salts of carboxamides for the treatment of joint disease
DE10106852A1 (de) * 2001-02-14 2002-09-05 T Luger Entzündungshemmende Verbindungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US4853409A (en) * 1988-04-13 1989-08-01 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function
DE4111305C2 (de) * 1991-04-08 1994-12-01 Mack Chem Pharm Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
DE4111306C2 (de) * 1991-04-08 1994-06-01 Mack Chem Pharm Pharmazeutische Zubereitungen, die ein 2-Oxindol-l-carboxamid-derivat enthalten und zur Injektion bestimmt sind
US5298522A (en) * 1993-01-22 1994-03-29 Pfizer Inc. 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio

Also Published As

Publication number Publication date
JP2711939B2 (ja) 1998-02-10
HU9400176D0 (en) 1994-05-30
NO952904D0 (no) 1995-07-21
AP9400609A0 (en) 1994-01-31
YU48719B (sh) 1999-07-28
EP0680321B1 (en) 1998-09-23
FI940309A0 (fi) 1994-01-21
CA2153050A1 (en) 1994-08-04
ES2122236T3 (es) 1998-12-16
DZ1748A1 (fr) 2002-02-17
EP0680321A1 (en) 1995-11-08
BR9405661A (pt) 1995-11-21
LV10920A (lv) 1995-12-20
SK91395A3 (en) 1996-12-04
IL108326A0 (en) 1994-04-12
HUT69687A (en) 1995-09-28
FI940309A (fi) 1994-07-23
PL309957A1 (en) 1995-11-13
DK0680321T3 (da) 1999-06-14
DE69413518D1 (en) 1998-10-29
OA10173A (en) 1996-12-18
AU671533B2 (en) 1996-08-29
BG99767A (bg) 1996-02-28
CA2153050C (en) 1998-12-29
BG61966B1 (bg) 1998-11-30
DE69413518T2 (de) 1999-02-11
MA23095A1 (fr) 1994-10-01
UY23723A1 (es) 1994-06-28
AP468A (en) 1996-03-05
CN1116822A (zh) 1996-02-14
WO1994016694A1 (en) 1994-08-04
NZ261449A (en) 1996-08-27
NO952904L (no) 1995-07-21
LV10920B (en) 1996-04-20
CZ182895A3 (en) 1996-01-17
ATE171373T1 (de) 1998-10-15
AU6019894A (en) 1994-08-15
JPH08501109A (ja) 1996-02-06

Similar Documents

Publication Publication Date Title
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
FI970825A (fi) Farmaseuttiset koostumukset, jotka aktiivisen yhdisteen biologisen hyötyosuuden lisäämiseksi sisältävät sappisuolaa ja puskuria
FI952797A (fi) D-vitamiinianalogin uusi kiteinen muoto
ID17863A (id) Komposisi-komposisi farmasi yang terdiri dari siklosporin
IT8621358A0 (it) Composizione farmaceutica adattivita' analgesica.
ES2173858T3 (es) Analogos de huperzina a.
PL309282A1 (en) Application of 2-amino-6-n-propyl-amino- 4,5,6,7-tetrahydrobenzothiasole (pramipexol) as an antidepressant
MX9302116A (es) Compuestos azabiciclo.
YU2394A (sh) Lizin so 6-hloro-5-fluoro-3-(-2-tenoil)-2-oksindol-1-karboksamida
IT8520234A0 (it) Composizione farmaceutiche adattivita' dopominergica.
DE3650221D1 (de) Penemderivate.
ATE90195T1 (de) Minoxidil-gel.
DE69614552T2 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
MY100083A (en) Diazepinoindoles, their production and pharmaceutical compositions containing them.
IT1224244B (it) Composizione farmaceutica anoressizzante comprendente 5-idrossitrpofano
GR1001368B (el) Φαρμακευτικοί φορείς.
IT9048605A0 (it) Derivati della 1,2,3,4,-tetraidronaftilammina ad attivita' nootropica e composizioni farmaceutiche che li contengono.
ITMI921477A0 (it) Derivato dell'alfa tocoferolo solubile
IT8847610A0 (it) Composizioni farmaceutiche adattivita' antiprolattinica
CO4770982A1 (es) Nuevas formulaciones
IT8820659A0 (it) Derivato dell'alfa tocoferolo solubile.
BR1100696A (pt) Composição consistindo essencialmente de um veìculo farmaceuticamente aceitável, uma prostaglandina livre e uma partìcula
IT8920836A0 (it) Derivato dell'alfa tocoferolo solubile.
IT8747873A0 (it) Composizione farmaceutica ad attivi ta' mucolitica
ITMI930218A0 (it) Derivato peptico della rimantadina ad attivita' immunomodulante